| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.03M | - | |
| VP | 153.9K | $12.31M | -3,500 | |
| Other | 87.3K | $6.98M | - | |
| VP | 73.6K | $5.89M | -15,000 | |
| CFO | 70.1K | $5.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 2,000 | $21.48 | $42,951.60 | -1.2% | +44.6% | +83.6% | |
| Jun 3, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $20.61 | $103,043.50 | -1.4% | +56.9% | +103.8% | |
| Jun 1, 2021 | Cragg David | Chief Hr &Admin Officer | Sale+OE | 14,999 | $21.63 | $324,389.37 | -4.4% | +50.5% | +86.5% | |
| May 20, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $23.71 | $118,548.50 | -1.4% | +26.9% | +66.8% | |
| May 13, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 2,000 | $24.42 | $48,840.00 | -1.2% | +28.9% | +66.5% | |
| May 7, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $23.21 | $116,041.00 | -1.4% | +24.8% | +57.1% | |
| Apr 30, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $25.87 | $129,361.00 | -1.4% | +15.4% | +56.7% | |
| Apr 27, 2021 | Smith Sandford D48 | Director | Sale+OE | 9,739 | $27.76 | $270,322.50 | -84.1% | +5.4% | +29.6% | |
| Apr 26, 2021 | Smith Sandford D48 | Director | Sale+OE | 5,000 | $27.00 | $135,000.00 | -84.5% | +4.5% | +25.7% | |
| Apr 23, 2021 | Smith Sandford D48 | Director | Sale+OE | 5,000 | $26.50 | $132,500.00 | -84.5% | +13.6% | +35.6% |